Compare Apple Inc (AAPL) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Apple Inc vs Cronos Group Inc — how do they compare? Apple Inc trades at $309.3 (market cap $4.50T), while Cronos Group Inc trades at $3.06 (market cap $1.11B). The key difference: Apple Inc is far larger — about 4054.1× Cronos Group Inc's market cap, and Apple Inc pays a 0.35% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| AAPL | CRON | |
|---|---|---|
Market Cap | $4.50T | $1.11B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $340.08 | $3.27 |
52-Week Low | $224.90 | $2.30 |
Enterprise Value | $4.52T | $310.67M |
Dividend Yield | 0.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Apple (AAPL) trades at $313.33, up 0.29% with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters with Q2 2026 EPS of $2.02 beating expectations of $1.89. Revenue growth accelerated to $416.16B in 2025 with net income reaching $112.01B. Analyst consensus remains positive with 63.6% buy ratings and a $337.63 price target, though recent news highlights union tensions and potential Q3 earnings pressure.
Apple's outlook remains favorable with strong cash flow generation and market leadership in smartphones. Key opportunities include AI integration through 2.5B active devices and partnership with Alphabet's Gemini. Risks include union disputes, regulatory scrutiny from EU fines exceeding $7B, and competitive pressures. The stock trades at premium valuations (P/E 35.93) requiring sustained execution to justify current levels.
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
